Cytiva, 29295127, Xuri™ IL-2 growth factor

Xuri IL-2 Syringe Interleukin-2 available in two formats – powder or liquid. This growth factor reliably activates T lymphocytes for efficient cell expansion. Meets USP <1043> for cell therapy ancillary material as applicable to supplier. • Gain peace of mind. Produced under a certified GMP license regularly qualified by licensing authorities. Sterility- and endotoxin-tested according to USP. • Reproducible. No need to revalidate each new lot. • Manage contamination risk. Easily connect Xuri IL-2 Syringe to a bag via Luer connection. Functionality of this product is based on biological activity assays. Animal component-free. All Xuri reagents and media are compatible with Xuri Cell Expansion System. Interleukin-2 Interleukin-2 promotes the growth, activity and maintenance of T and B lymphocytes. IL-2 is key in a number of cell and cell-based gene therapies. Regulatory support Regulatory support file (RSF) is available . Quality statement Xuri growth factors are manufactured, tested, and released in compliance with relevant cGMP guidelines. USP Chapter ‹1043› ‘Ancillary materials for cell, gene and tissue-engineered products’ has been followed in the design of these products.